Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe
Posted on: February 27, 2009 - Filed under
The Official Website of the Acid Maltase Deficiency Association
It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. - Robert H. Goddard
Other News
Get Involved
Your generous contribution will go a long way into improving the quality of life of Pompe Disease Patients worldwide.
Recently Added Items
- Announcement Regarding 160 liter Myozyme Supply was posted in News, last January 17, 2012
- Conference Report Available for 2011 AMDA/IPA Patient and Scientific Conference was posted in Patient Conferences, last January 15, 2012
- Spinal Delivery of AAV Vector Restores Enzyme Activity and Increases Ventilation in Pompe Mice was posted in Publications, last January 01, 2012
- Inspired By Pompe Cookbooks available for Sale! was posted in News, last December 06, 2011
- Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease was posted in News, last December 01, 2011
© 2011 Acid Maltase Deficiency Association
Disclaimer: The AMDA does not endorse any of the products, medications, treatments or information reported herein. The website and its contents is intended for informational purposes, only. We strongly advise that you discuss all medications, treatments, and/or products with your physician.